Crown Laboratories completes acquisition of Revance Therapeutics

Health Care · United States · Undisclosed

Crown Laboratories, a Hildred Capital Partners portfolio company, completed its acquisition of Revance Therapeutics in February 2025, later adopting the Revance name for the combined skincare and aesthetics company.